vs
CaliberCos Inc.（CWD）与Prelude Therapeutics Inc（PRLD）财务数据对比。点击上方公司名可切换其他公司
Prelude Therapeutics Inc的季度营收约是CaliberCos Inc.的1.6倍（$6.5M vs $4.1M），CaliberCos Inc.净利率更高（-188.3% vs -303.5%，领先115.1%），Prelude Therapeutics Inc同比增速更快（116.7% vs -52.5%）
CaliberCos Inc.是一家总部位于美国的另类资产管理企业，核心业务涵盖房地产投资、资产运营及增值开发板块，服务对象包含机构投资者、高净值人群与零售投资者，业务布局主要集中在北美地区。
CWD vs PRLD — 直观对比
营收规模更大
PRLD
是对方的1.6倍
$4.1M
营收增速更快
PRLD
高出169.2%
-52.5%
净利率更高
CWD
高出115.1%
-303.5%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.1M | $6.5M |
| 净利润 | $-7.7M | $-19.7M |
| 毛利率 | — | — |
| 营业利润率 | -196.6% | -314.1% |
| 净利率 | -188.3% | -303.5% |
| 营收同比 | -52.5% | 116.7% |
| 净利润同比 | 32.2% | 38.9% |
| 每股收益（稀释后） | $1.95 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CWDPRLD
| Q4 25 | $4.1M | — | ||
| Q3 25 | $3.6M | $6.5M | ||
| Q2 25 | $5.1M | — | ||
| Q1 25 | $7.3M | — | ||
| Q4 24 | $8.7M | — | ||
| Q3 24 | $11.3M | $3.0M | ||
| Q2 24 | $8.2M | — | ||
| Q1 24 | $23.0M | — |
净利润CWDPRLD
| Q4 25 | $-7.7M | — | ||
| Q3 25 | $-4.4M | $-19.7M | ||
| Q2 25 | $-5.3M | — | ||
| Q1 25 | $-4.4M | — | ||
| Q4 24 | $-11.4M | — | ||
| Q3 24 | $146.0K | $-32.3M | ||
| Q2 24 | $-4.7M | — | ||
| Q1 24 | $-3.8M | — |
营业利润率CWDPRLD
| Q4 25 | -196.6% | — | ||
| Q3 25 | -129.6% | -314.1% | ||
| Q2 25 | -112.4% | — | ||
| Q1 25 | -62.7% | — | ||
| Q4 24 | -236.8% | — | ||
| Q3 24 | 0.0% | -1145.9% | ||
| Q2 24 | -65.0% | — | ||
| Q1 24 | -22.9% | — |
净利率CWDPRLD
| Q4 25 | -188.3% | — | ||
| Q3 25 | -120.2% | -303.5% | ||
| Q2 25 | -104.5% | — | ||
| Q1 25 | -60.7% | — | ||
| Q4 24 | -247.6% | — | ||
| Q3 24 | 1.3% | -1075.7% | ||
| Q2 24 | -57.8% | — | ||
| Q1 24 | -16.6% | — |
每股收益（稀释后）CWDPRLD
| Q4 25 | $1.95 | — | ||
| Q3 25 | $-1.65 | $-0.26 | ||
| Q2 25 | $-4.15 | — | ||
| Q1 25 | $-3.85 | — | ||
| Q4 24 | $-10.15 | — | ||
| Q3 24 | $0.12 | $-0.43 | ||
| Q2 24 | $-4.34 | — | ||
| Q1 24 | $-3.53 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.9M | $55.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3M | $58.5M |
| 总资产 | $135.4M | $94.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CWDPRLD
| Q4 25 | $2.9M | — | ||
| Q3 25 | $10.9M | $55.0M | ||
| Q2 25 | $683.0K | — | ||
| Q1 25 | $1.6M | — | ||
| Q4 24 | $2.3M | — | ||
| Q3 24 | $1.6M | $153.6M | ||
| Q2 24 | $1.8M | — | ||
| Q1 24 | $2.1M | — |
股东权益CWDPRLD
| Q4 25 | $1.3M | — | ||
| Q3 25 | $4.2M | $58.5M | ||
| Q2 25 | $-19.9M | — | ||
| Q1 25 | $-15.8M | — | ||
| Q4 24 | $-12.6M | — | ||
| Q3 24 | $-3.8M | $156.4M | ||
| Q2 24 | $-4.7M | — | ||
| Q1 24 | $-745.0K | — |
总资产CWDPRLD
| Q4 25 | $135.4M | — | ||
| Q3 25 | $82.6M | $94.8M | ||
| Q2 25 | $59.3M | — | ||
| Q1 25 | $103.6M | — | ||
| Q4 24 | $105.5M | — | ||
| Q3 24 | $158.6M | $197.2M | ||
| Q2 24 | $195.2M | — | ||
| Q1 24 | $201.5M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-12.1M | $-19.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CWDPRLD
| Q4 25 | $-12.1M | — | ||
| Q3 25 | $-4.6M | $-19.1M | ||
| Q2 25 | $-1.2M | — | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $555.0K | — | ||
| Q3 24 | $-74.0K | $-27.3M | ||
| Q2 24 | $1.4M | — | ||
| Q1 24 | $-1.5M | — |
自由现金流CWDPRLD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-27.4M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率CWDPRLD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -912.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度CWDPRLD
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率CWDPRLD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.51× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
